2025年的短期課程

Monday, 10 November, 2025

SC1: Best Practices and Advanced Applications for Label-Free Interaction Analysis in Therapeutic Antibody Discovery

Yasmina Abdiche, PhD, Senior Vice President, Exploratory Research, OmniAb Inc.

SC2: Best Practices for Targeting GCPRs, Ion Channels, and Transporters with Monoclonal Antibodies

Ross Chambers, PhD, Vice President, Antibody Discovery, Integral Molecular, Inc.

SC3: Developability of Bispecific Antibodies

Nimish Gera, PhD, Vice President, Biologics, Mythic Therapeutics

SC4: In silico and Machine Learning Tools for Antibody Design and Developability Predictions

Rahmad Akbar, PhD, Senior Data Scientist, Antibody Design, Novo Nordisk

Vinodh B. Kurella, PhD, Biotherapeutic Computational Modeler, Takeda Pharmaceuticals, Inc.

Odysseas Vavourakis, Generative Antibody Design, University of Oxford

SC5: Novel Payloads and Conjugation Strategies - Building on Lessons Learned to Inform Next-Generation ADC Design

Lenka Sadilkova, PhD, Head, Preclinical R&D, Mablink

* 活動內容有可能不事先告知作更動及調整。

Choose your language

會議議程

工程分會